Table 1.
Patient characteristics
| Characteristics (N= 24) | Value |
|---|---|
|
| |
| Age (years): Mean (range) | 71.1 (53–87) |
|
| |
| Treatment completed (cycles): Mean (range) | 7.9 (1–23) |
|
| |
| PSA level (ng/mL): Mean (range) | 43.4 (2.5–556.9) |
|
| |
| Race, number (%) | |
| Caucasian | 20 (87.5%) |
| African-American | 3 (8.33%) |
| Asian | 1 (4.17%) |
|
| |
| Gleason Score | |
| <7 | 1 (4%) |
| 7–10 | 21(88%) |
| Not available | 2 (8%) |
|
| |
| Site of Disease: prior to treatment | |
| Bone | 14 (58%) |
| Nodes | 3 (13%) |
| Bone and Nodes | 3 (13%) |
| PSA only | 2 (8%) |
| Bladder | 1 (4%) |
| Liver | 1 (4%) |
|
| |
| Prior chemotherapy | |
| 1 Line (docetaxel) | 1 (4%) |
| 2 Lines or more | 0 (0%) |